Kate Liebelt
Class of 2025-2026
Former Executive Chief of Staff to the CEO, Parker Institute for Cancer Immunotherapy
Kate grew up in Ohio and Japan, went to Washington University in St. Louis, and began her career in healthcare at Baxter International. She moved on to Takeda, PwC, Deloitte, AbbVie, Organon, and Genentech-Roche before joining the Parker Institute for Cancer Immunotherapy in 2025. Kate helps guide the Institute’s strategy, operations, and governance to accelerate cancer research and life-saving therapies.